Quantum Immunologics’ Alternative to Chemotherapy
The company’s vaccine technology is based on the universal tumor antigen, which has been expressed in all human cancers studied so far.
quantum immunologics
Quantum Immunologics at the 2010 OneMedForum
Charles Broes, CEO and Chairman of the Board of Quantum Immunologics, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San […]
Cancer Vaccines: Investing Opportunities Beyond Dendreon
Despite the setbacks and pitfalls experienced by early-stage pioneers in the cancer immunotherapy / therapeutic cancer vaccine space, recent advancements and study results are encouraging.